F Passamonti Selected Research

F Passamonti Research Topics

Disease

8	Primary Myelofibrosis (Myelosclerosis) 01/2017 - 10/2000
6	Neoplasms (Cancer) 01/2017 - 10/2000
3	Splenomegaly 01/2017 - 02/2011
3	Essential Thrombocythemia 07/2014 - 10/2002
2	Infections 12/2017 - 02/2015
2	Fever (Fevers) 06/2017 - 01/2017
2	Leukocytosis (Pleocytosis) 05/2012 - 04/2012
2	Thrombocytosis (Thrombocythemia) 05/2012 - 04/2012
2	Polycythemia Vera 05/2012 - 10/2000
2	Polycythemia (Erythrocytosis) 05/2012 - 02/2009
1	Weight Loss (Weight Reduction) 01/2017
1	Pruritus (Itching) 01/2017
1	Neutropenia 01/2017
1	Pneumonia (Pneumonitis) 02/2015
1	Abscess 02/2015
1	Abnormal Karyotype 09/2013
1	Pyoderma 06/2012
1	Thrombosis (Thrombus) 05/2012
1	Hemorrhage 04/2012
1	Endometritis 08/2011
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2011
1	Anemia 02/2011
1	MYH9-Related Disorders 12/2009
1	Bernard-Soulier Syndrome (Giant Platelet Syndrome) 12/2009
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2009
1	Thrombocytopenia (Thrombopenia) 12/2009
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2008
1	Lymphoma (Lymphomas) 02/2007
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2002
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2002
1	Multiple Myeloma 04/2001
1	Bone Diseases (Bone Disease) 04/2001
1	Bone Resorption 04/2001
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 03/2001
1	Keratoacanthoma 03/2001
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2001
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 03/2001
1	Leukemia 10/2000
1	Hodgkin Disease (Hodgkin's Disease) 10/2000

Drug/Important Bio-Agent (IBA)

3	ruxolitinibIBA 01/2017 - 02/2011
3	Hydroxyurea (Hydrea)FDA LinkGeneric 05/2012 - 03/2001
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2017 - 06/2012
2	pomalidomideIBA 01/2017 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2015 - 02/2011
2	Erythropoietin FDA Link 05/2012 - 02/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2012 - 02/2010
2	Pipobroman (Vercyte)FDA Link 10/2002 - 10/2000
1	NucleotidesIBA 12/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 02/2015
1	Fibrinogen (Factor I)FDA Link 02/2015
1	CalreticulinIBA 07/2014
1	Dihydrotachysterol (AT 10)IBA 09/2013
1	SuperantigensIBA 08/2011
1	Imatinib Mesylate (Gleevec)FDA Link 02/2011
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 02/2011
1	fedratinibIBA 02/2011
1	Janus Kinase InhibitorsIBA 02/2011
1	Janus KinasesIBA 02/2011
1	Ikaros Transcription FactorIBA 07/2010
1	Inosine Triphosphate (ITP)IBA 12/2009
1	Oxygen (Dioxygen)IBA 02/2009
1	2,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)IBA 02/2009
1	Antiviral Agents (Antivirals)IBA 02/2007
1	Biomarkers (Surrogate Marker)IBA 04/2001
1	OsteocalcinIBA 04/2001
1	Alkaline PhosphataseIBA 04/2001
1	AntimetabolitesIBA 03/2001

Therapy/Procedure

9	Therapeutics 06/2017 - 10/2000
1	Stem Cell Transplantation 11/2015
1	Adjuvant Radiotherapy 10/2000
1	Combined Modality Therapy 10/2000
1	Drug Therapy (Chemotherapy) 10/2000
1	Laparotomy 10/2000